RhumbLine Advisers’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Buy |
144,163
+4,318
| +3% | +$277K | 0.01% | 1061 |
|
|
2026
Q1 | $7.88M | Sell |
139,845
-561
| -0.4% | -$36.5K | 0.01% | 1183 |
|
|
2025
Q4 | $11.3M | Sell |
140,406
-16,466
| -10% | -$1.11M | 0.01% | 1006 |
|
|
2025
Q3 | $7.65M | Sell |
156,872
-9,535
| -6% | -$590K | 0.01% | 1214 |
|
|
2025
Q2 | $12.4M | Buy |
166,407
+5,284
| +3% | +$350K | 0.01% | 965 |
|
|
2025
Q1 | $10.2M | Buy |
161,123
+1,861
| +1% | +$127K | 0.01% | 1007 |
|
|
2024
Q4 | $12.4M | Buy |
159,262
+1,024
| +0.6% | +$82.2K | 0.01% | 955 |
|
|
2024
Q3 | $12.7M | Sell |
158,238
-3,423
| -2% | -$277K | 0.01% | 954 |
|
|
2024
Q2 | $13.4M | Buy |
161,661
+842
| +0.5% | +$74.1K | 0.01% | 889 |
|
|
2024
Q1 | $13.7M | Buy |
160,819
+741
| +0.5% | +$58.2K | 0.01% | 899 |
|
|
2023
Q4 | $13.7M | Sell |
160,078
-2,855
| -2% | -$247K | 0.01% | 885 |
|
|
2023
Q3 | $14.6M | Buy |
162,933
+1,118
| +0.7% | +$99.8K | 0.02% | 796 |
|
|
2023
Q2 | $13.8M | Sell |
161,815
-114
| -0.1% | -$9.64K | 0.02% | 848 |
|
|
2023
Q1 | $13.4M | Sell |
161,929
-1,623
| -1% | -$131K | 0.02% | 820 |
|
|
2022
Q4 | $12.9M | Sell |
163,552
-905
| -0.6% | -$72.7K | 0.02% | 812 |
|
|
2022
Q3 | $12.2M | Buy |
164,457
+6,821
| +4% | +$490K | 0.02% | 789 |
|
|
2022
Q2 | $10.3M | Buy |
157,636
+8,866
| +6% | +$525K | 0.02% | 885 |
|
|
2022
Q1 | $9.4M | Buy |
148,770
+2,817
| +2% | +$153K | 0.01% | 983 |
|
|
2021
Q4 | $7.74M | Buy |
145,953
+4,620
| +3% | +$281K | 0.01% | 1125 |
|
|
2021
Q3 | $9.98M | Buy |
141,333
+1,085
| +0.8% | +$68.5K | 0.01% | 954 |
|
|
2021
Q2 | $9.35M | Buy |
140,248
+3,192
| +2% | +$226K | 0.01% | 1047 |
|
|
2021
Q1 | $15.2M | Sell |
137,056
-1,831
| -1% | -$227K | 0.02% | 738 |
|
|
2020
Q4 | $16.5M | Sell |
138,887
-140
| -0.1% | -$15.1K | 0.02% | 637 |
|
|
2020
Q3 | $12.1M | Sell |
139,027
-4,694
| -3% | -$410K | 0.02% | 675 |
|
|
2020
Q2 | $12.9M | Sell |
143,721
-9,053
| -6% | -$914K | 0.02% | 655 |
|
|
2020
Q1 | $15.2M | Sell |
152,774
-1,745
| -1% | -$189K | 0.03% | 478 |
|
|
2019
Q4 | $17.8M | Sell |
154,519
-904
| -0.6% | -$109K | 0.03% | 531 |
|
|
2019
Q3 | $19.6M | Sell |
155,423
-7,044
| -4% | -$894K | 0.04% | 452 |
|
|
2019
Q2 | $19.6M | Buy |
162,467
+2,645
| +2% | +$260K | 0.04% | 454 |
|
|
2019
Q1 | $14M | Buy |
159,822
+224
| +0.1% | +$20.4K | 0.03% | 584 |
|
|
2018
Q4 | $16M | Buy |
159,598
+64,530
| +68% | +$6.78M | 0.03% | 507 |
|
|
2018
Q3 | $10.9M | Sell |
95,068
-6,361
| -6% | -$659K | 0.02% | 644 |
|
|
2018
Q2 | $9.1M | Sell |
101,429
-24,892
| -20% | -$2.1M | 0.02% | 726 |
|
|
2018
Q1 | $9.24M | Buy |
126,321
+3,462
| +3% | +$238K | 0.02% | 700 |
|
|
2017
Q4 | $7.14M | Buy |
122,859
+18,190
| +17% | +$958K | 0.01% | 849 |
|
|
2017
Q3 | $4.7M | Buy |
104,669
+2,145
| +2% | +$89.1K | 0.01% | 1078 |
|
|
2017
Q2 | $4.05M | Sell |
102,524
-3,747
| -4% | -$154K | 0.01% | 1127 |
|
|
2017
Q1 | $4.31M | Buy |
106,271
+25,945
| +32% | +$1.01M | 0.01% | 1097 |
|
|
2016
Q4 | $3.23M | Sell |
80,326
-3,396
| -4% | -$128K | 0.01% | 1169 |
|
|
2016
Q3 | $3.03M | Buy |
83,722
+3,615
| +5% | +$124K | 0.01% | 1152 |
|
|
2016
Q2 | $2.32M | Sell |
80,107
-1,462
| -2% | -$44.2K | 0.01% | 1244 |
|
|
2016
Q1 | $2.85M | Buy |
81,569
+6,060
| +8% | +$196K | 0.01% | 1147 |
|
|
2015
Q4 | $2.43M | Buy |
75,509
+935
| +1% | +$30.3K | 0.01% | 1223 |
|
|
2015
Q3 | $2.41M | Sell |
74,574
-1,191
| -2% | -$44.8K | 0.01% | 1215 |
|
|
2015
Q2 | $3.13M | Sell |
75,765
-10,835
| -13% | -$457K | 0.01% | 1123 |
|
|
2015
Q1 | $3.89M | Buy |
86,600
+865
| +1% | +$36.2K | 0.01% | 979 |
|
|
2014
Q4 | $3.21M | Buy |
85,735
+555
| +0.7% | +$20.3K | 0.01% | 1053 |
|
|
2014
Q3 | $2.97M | Sell |
85,180
-2,930
| -3% | -$105K | 0.01% | 1058 |
|
|
2014
Q2 | $3.11M | Buy |
88,110
+10,276
| +13% | +$343K | 0.01% | 1087 |
|
|
2014
Q1 | $2.54M | Sell |
77,834
-2,900
| -4% | -$111K | 0.01% | 1200 |
|
|
2013
Q4 | $3.4M | Buy |
80,734
+3,630
| +5% | +$149K | 0.01% | 1032 |
|
|
2013
Q3 | $3.08M | Sell |
77,104
-2,034
| -3% | -$85.3K | 0.01% | 1079 |
|
|
2013
Q2 | $3.27M | Buy |
+79,138
| New | +$3.2M | 0.01% | 1007 |
|
Other funds holding HAE
AI
RhumbLine Advisers's HAE Position: Q2 2026 in Review
RhumbLine Advisers increased its Haemonetics (HAE) stake by 3.1% in Q2 2026, buying an estimated $277K and bringing the position to 144,163 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1061.
RhumbLine Advisers first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.6M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- RhumbLine Advisers held 144,163 shares of Haemonetics worth $10.8M as of Q2 2026.
- RhumbLine Advisers bought 4,318 Haemonetics shares in Q2 2026, an estimated $277K.
- Haemonetics made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1061 holding.
- RhumbLine Advisers first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Haemonetics position peaked at $19.6M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.